Diagnostic Kits/Bibliography by Resource Type: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
==Academic Articles and Papers==
==Academic Articles and Papers==


*Caulfield, Timothy, 2009. Do Gene Patents Hurt Research? Available at: http://www.scienceprogress.org/2009/10/do-gene-patents-hurt-research/comment-page-1/#comment-6370
*Caulfield, Timothy, 2009. ''Do Gene Patents Hurt Research?'' Available at: http://www.scienceprogress.org/2009/10/do-gene-patents-hurt-research/comment-page-1/#comment-6370


*Cho, M.K. et al., 2003. Effects of patents and licenses on the provision of clinical genetic testing services. The Journal of Molecular Diagnostics: JMD, 5(1), 3-8. Available at: http://jmd.amjpathol.org/cgi/content/full/5/1/3 [Accessed August 10, 2009].  
*Cho, M.K. et al., 2003. ''Effects of patents and licenses on the provision of clinical genetic testing services''. The Journal of Molecular Diagnostics: JMD, 5(1), 3-8. Available at: http://jmd.amjpathol.org/cgi/content/full/5/1/3 [Accessed August 10, 2009].  
**[[Diagnostic_Kits/Effects of patents and licenses on the provision of clinical genetic testing services|Highlights]]
**[[Diagnostic_Kits/Effects of patents and licenses on the provision of clinical genetic testing services|Highlights]]


*Cohen, W.M., Merrill, S.A. & Economy, N.R.C., 2003. Patents in the knowledge-based economy, National Academies Press.
*Cohen, W.M., Merrill, S.A. & Economy, N.R.C., 2003. ''Patents in the knowledge-based economy'', National Academies Press.


**Cook-Deegan, R., Chandrasekharan, S. & Angrist, M., 2009. The dangers of diagnostic monopolies. Nature, 458(7237), 405-406.
**Cook-Deegan, R., Chandrasekharan, S. & Angrist, M., 2009. ''The dangers of diagnostic monopolies''. Nature, 458(7237), 405-406.
**[[Diagnostic_Kits/The dangers of diagnostic monopolies|Highlights]]
**[[Diagnostic_Kits/The dangers of diagnostic monopolies|Highlights]]


*Eisenberg, R. Noncompliance, 2008. Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research. Houston Law Review Available at: # www.houstonlawreview.org/archive/downloads/45-4_pdf/03_​Eisenberg.pdf [Accessed November 20, 2009].
*Eisenberg, R. Noncompliance, 2008. ''Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research''. Houston Law Review Available at: # www.houstonlawreview.org/archive/downloads/45-4_pdf/03_​Eisenberg.pdf [Accessed November 20, 2009].
**[[Diagnostic_Kits/Nonenforcement, Noneproblem Rethinking the Anticommons in Biomedical Research|Highlights]]
**[[Diagnostic_Kits/Nonenforcement, Noneproblem Rethinking the Anticommons in Biomedical Research|Highlights]]


*Elfenbein, D.W., 2006. Publications, Patents, and the Market for University Inventions. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=739227 [Accessed October 2, 2009].
*Elfenbein, D.W., 2006. ''Publications, Patents, and the Market for University Inventions''. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=739227 [Accessed October 2, 2009].


* Farkas and Holland. Direct-to-consumer genetic testing: two sides of the coin. The Journal of molecular diagnostics : JMD (2009) vol. 11 (4) pp. 263-5. [Accessed 14 Dec 2009: http://jmd.amjpathol.org/cgi/content/full/11/4/263]  
* Farkas and Holland. ''Direct-to-consumer genetic testing: two sides of the coin''. The Journal of molecular diagnostics : JMD (2009) vol. 11 (4) pp. 263-5. [Accessed 14 Dec 2009: http://jmd.amjpathol.org/cgi/content/full/11/4/263]  
** [[Diagnostic_Kits/Direct-to-consumer genetic testing- two sides of the coin|Highlights]]
** [[Diagnostic_Kits/Direct-to-consumer genetic testing- two sides of the coin|Highlights]]


* Flockhart et al. Clinically Available Pharmacogenomics Tests. Clinical Pharmacology & Therapeutics (2009)  Available at: http://www.nature.com/clpt/journal/v86/n1/abs/clpt200939a.html
* Flockhart et al. ''Clinically Available Pharmacogenomics Tests. Clinical Pharmacology & Therapeutics'' (2009)  Available at: http://www.nature.com/clpt/journal/v86/n1/abs/clpt200939a.html
** [[Diagnostic_Kits/Clinically Available Pharmacogenomics Tests|Highlights]]
** [[Diagnostic_Kits/Clinically Available Pharmacogenomics Tests|Highlights]]


*Furness, et. al. The evaluation of diagnostic laboratory tests and complex biomarkers, (2008) Available at: http://www.phgfoundation.org/pages/work7.htm
*Furness, et. al. ''The evaluation of diagnostic laboratory tests and complex biomarkers'', (2008) Available at: http://www.phgfoundation.org/pages/work7.htm


*Garcia, L. & Shimizu, R., 1997. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol., 35(6), 1526-1529.
*Garcia, L. & Shimizu, R., 1997. ''Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens''. J. Clin. Microbiol., 35(6), 1526-1529.


*Geertrui Van Overwalle et al., 2005. Models for facilitating access to patents on genetic inventions. Available at: http://www.nature.com/nrg/journal/v7/n2/full/nrg1765.html [Accessed August 10, 2009].
*Geertrui Van Overwalle et al., 2005. ''Models for facilitating access to patents on genetic inventions''. Available at: http://www.nature.com/nrg/journal/v7/n2/full/nrg1765.html [Accessed August 10, 2009].
**[[Diagnostic_Kits/Models for facilitating access to patents on genetic inventions|Highlights]]
**[[Diagnostic_Kits/Models for facilitating access to patents on genetic inventions|Highlights]]


*Gibson, J., The Discovery of Invention: Gene Patents and the Question of Patentability. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1347087 [Accessed October 29, 2009].
*Gibson, J., ''The Discovery of Invention: Gene Patents and the Question of Patentability''. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1347087 [Accessed October 29, 2009].


*Goodman et al. The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care.  (2005) pp. 44-71.  Available at: http://www.advamed.org/MemberPortal/About/Resources/
*Goodman et al. ''The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care''.  (2005) pp. 44-71.  Available at: http://www.advamed.org/MemberPortal/About/Resources/
** [[Diagnostic_Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care|Highlights]]
** [[Diagnostic_Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care|Highlights]]


*Helene Dernis, 2007. Nowcasting Patent Indicators, OECD, Directorate for Science, Technology and Industry. Available at: http://ideas.repec.org/p/oec/stiaaa/2007-3-en.html.
*Helene Dernis, 2007. ''Nowcasting Patent Indicators, OECD, Directorate for Science, Technology and Industry''. Available at: http://ideas.repec.org/p/oec/stiaaa/2007-3-en.html.


*Heller, M.A. & Eisenberg, R.A. Can patents deter innovation? The anticommons in biomedical research. Science 280, 698-701 (1998).  
*Heller, M.A. & Eisenberg, R.A. ''Can patents deter innovation? The anticommons in biomedical research''. Science 280, 698-701 (1998).  


*Henry, M. et al. 2002. DNA Patenting and Licensing Available at: http://www.bioethics.upenn.edu/prog/ethicsgenes/pdf/henry_etal_Science20020823.pdf [Accessed August 5, 2009].
*Henry, M. et al. 2002. ''DNA Patenting and Licensing''. Available at: http://www.bioethics.upenn.edu/prog/ethicsgenes/pdf/henry_etal_Science20020823.pdf [Accessed August 5, 2009].
**[[Diagnostic_Kits/DNA Patenting and Licensing|Highlights]]
**[[Diagnostic_Kits/DNA Patenting and Licensing|Highlights]]


*Henry, M.R., Cho, M.K., Weaver, M.A., Merz, J.F. A pilot survey on the licensing of DNA inventions. J. Law Med. Ethics, 31:442-449, 2003 Available at: http://www.bioethics.upenn.edu:16080/prog/ethicsgenes/ [Accessed September 10, 2009].
*Henry, M.R., Cho, M.K., Weaver, M.A., Merz, J.F. ''A pilot survey on the licensing of DNA inventions''. J. Law Med. Ethics, 31:442-449, 2003 Available at: http://www.bioethics.upenn.edu:16080/prog/ethicsgenes/ [Accessed September 10, 2009].
**[[Diagnostic_Kits/A pilot survey on the licensing of DNA inventions|Highlights]]
**[[Diagnostic_Kits/A pilot survey on the licensing of DNA inventions|Highlights]]


*Herder, M., Patents & the Progress of Personalized Medicine: Biomarkers Research as Lens. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1435468 [Accessed October 1, 2009].
*Herder, M., Patents & the Progress of Personalized Medicine: ''Biomarkers Research as Lens''. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1435468 [Accessed October 1, 2009].
**[[Diagnostic Kits/Patents and the Progress of Personalized Medicine|Highlights]]
**[[Diagnostic Kits/Patents and the Progress of Personalized Medicine|Highlights]]


*Hoag, H., 2004. Testing new ground. Nature, 429(6992), 682-3  
*Hoag, H., 2004. ''Testing new ground''. Nature, 429(6992), 682-3  
** [[Diagnostic_Kits/Testing new ground|Highlights]]
** [[Diagnostic_Kits/Testing new ground|Highlights]]



Revision as of 16:01, 17 April 2010

Academic Articles and Papers

  • Cohen, W.M., Merrill, S.A. & Economy, N.R.C., 2003. Patents in the knowledge-based economy, National Academies Press.
    • Cook-Deegan, R., Chandrasekharan, S. & Angrist, M., 2009. The dangers of diagnostic monopolies. Nature, 458(7237), 405-406.
    • Highlights
  • Eisenberg, R. Noncompliance, 2008. Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research. Houston Law Review Available at: # www.houstonlawreview.org/archive/downloads/45-4_pdf/03_​Eisenberg.pdf [Accessed November 20, 2009].
  • Garcia, L. & Shimizu, R., 1997. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J. Clin. Microbiol., 35(6), 1526-1529.
  • Heller, M.A. & Eisenberg, R.A. Can patents deter innovation? The anticommons in biomedical research. Science 280, 698-701 (1998).
  • Hoag, H., 2004. Testing new ground. Nature, 429(6992), 682-3
  • Holman, Christopher M., The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation. UMKC Law Review, Vol. 76, p. 295, 2007. Available at SSRN: http://ssrn.com/abstract=1090562
  • Holman, C.M., 2008. GENETICS: Trends in Human Gene Patent Litigation. Science, 322(5899), 198-199.
  • J.D, M.A.H.P. & Munzer, S.R., Intellectual Property Rights in Genes and Gene Fragments: A Registration Solution for Expressed Sequence Tags. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=241236 [Accessed October 30, 2009].
  • Jensen, K. & Murray, F., 2005. INTELLECTUAL PROPERTY: Enhanced: Intellectual Property Landscape of the Human Genome. Science, 310(5746), 239-240.
  • Kalorama Information (Rosen). Diagnostic Test Service Commercialization: A Roadmap to Diagnostics in the 21st Century. (2008)
  • Kaye, J., Hawkins, N., and J. Taylor. (2007). Patents and translational research in genomics. Nature Biotechnology 25(7):739.
  • Laakmann, A. Restoring the Genetic Commons: A "Common Sense" Approach to Biotechnology Patent in Restoring the Genetic Commons, Michigan Telecommunications and Technology Law Review 14 MITTLR 43 (2007).
  • McGill Centre for Intellectual Property Policy, 2005, Biotechnology and Intellectual Property: Reinventing the Commons: Workshop Report. Available at: www.cipp.mcgill.ca/data/events/00000017_en.pdf [Accessed November 20, 2009].
  • Merz, J.F., 2002. Patents limit medical potential of sequencing. Nature, 419(6910), 878.
  • Mills, A.E. & Tereskerz, P., 2008. DNA-based patents: an empirical analysis. Nat Biotech, 26(9), 993-995.
  • Mills, A.E. & Tereskerz, P.M., 2007. Changing patent strategies: what will they mean for the industry? Nat Biotech, 25(8), 867-868.
  • Morrison & Foerster : Legal Updates & News : Press Releases : Morrison & Foerster Represents ACON Laboratories in $175 Million Acquisition by Inverness Medical Innovations, Resolving Patent Litigation Between the Two Companies Over Rapid Diagnostic Techno. Available at: http://www.mofo.com/news/media/files/pr02058.html [Accessed August 5, 2009].
  • Muller, A et. al., Protecting Biotechnological Inventions in Brazil and Abroad: Draft, Scope and Protecting Biotechnological Inventions in Brazil and Abroad: Draft, Scope, and Interpretation of Claims 2002, Albany Law Journal of Science and Technology, 13 ALBLJST 145 (2002).
  • Nelson. The market economy, and the scientific commons. Research Policy (2004) vol. 33 (3) pp. 455-471
  • Palombi. The Search for Alternatives to Patents in the 21st Century.(2009) pp. 1-42
  • Paradise, J., European Opposition to Exclusive Control Over Predictive Breast Cancer Testing and the Inherent Implications for United States Patent Law and Public Policy: A Case Study of the Myriad Genetics' BRCA Patent Controversy. SSRN eLibrary. Available at: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=897507 [Accessed October 30, 2009].
  • Phillips, K.a., Van Bebber, S. & Issa, A.M., 2006. Diagnostics and biomarker development: priming the pipeline. Nature reviews. Drug discovery, 5(6), 463-9.
  • Pressman, L. et al., 2006. The licensing of DNA patents by US academic institutions: an empirical survey. Nat Biotech, 24(1), 31-39
  • Shapiro, C., Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard-Setting, 2001, Innovation Policy and the Economy (Vol. I) (Jaffe, Adam B. et al., eds), pp. 119-150, MIT Press, Available at: http://faculty.haas.berkeley.edu/shapiro/thicket.pdf [Accessed December 6, 2009]
  • Walsh JP, Arora A, Cohen WM. Effects of research tool patents and licensing on biomedical innovation. In: Cohen WM, Merrel SA, (editors). Patents in the knowledge-based economy. Washington (DC): The National Academies Press; 2003. p. 285-340.
  • Walsh, J. , Cho, C. & Cohen, W.M. Patents, Material Transfers and Access to Research Inputs in Biomedical Research (Final Report to the National Academy of Sciences' Committee [on] Intellectual Property Rights in Genomic and Protein-Related Research Inventions, 20 September 2005).
  • Wilson et al., Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation, 81 Clinical Pharmacology & Therapeutics 153 (2007).
  • Wolrad Prinz zu Waldeck und Pyrmont, Research Tool Patents After Integra v. Merck—Have They Reached a Safe Harbor?, 14 Mich. Telecomm. Tech. L. Rev. 367 (2008), available at http://www.mttlr.org/volfourteen/waldeck.pdf

Blogs & Social Media

Blogs

Twitter

http://twitter.com/100ideas/geneticdx - 8 experts on genetic/genomic diagnostics and personalized medicine

News

  • GEN- Genetic Engineering & Biotechnology News: Clinical Research & Diagnostics Channel (http://www.genengnews.com/transmed/)
    Content includes News, Articles, Tutorials, & Conferences/Meetings

Business Association' Publications

Civil Society Organizations Publications

Declarations and Manifestos

Governmental Resources and Reports

  • Ayme et al. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics. European Journal of Human Genetics (2008) vol. 16 Suppl 1 pp. S10-9
  • Secretary's Advisory Committee on Genetics, Health, and Society—Public Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests (Draft Report for Public Comment) [excerpts]. Biotechnology Law Report, 28(3), 417-442 (2009). Available at: http://oba.od.nih.gov/SACGHS/sacghs_documents.html#GHSDOC_011
  • *Secretary's Advisory Committee on Genetics, Health, and Society—Public Consultation Final Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests - September 17, 2009
  • *Secretary's Advisory Committee on Genetics, Health, and Society—Public Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests - Appendix 1: Compendium of Case Studies on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing. (2009) Available at: http://oba.od.nih.gov/SACGHS/sacghs_documents.html#GHSDOC_011.

Market Reports

Newspapers and Opinions

Databases and Statistics and Patents

Interviews

Completed

Recommended

Upcoming?

  • Jason Bobe
  • Dr. Joe Thakuria